Mizuho Securities Keeps Their Buy Rating on Rain Therapeutics (RAIN)

In a report released today, Graig Suvannavejh from Mizuho Securities maintained a Buy rating on Rain Therapeutics (RAIN – Research Report)...

Related Keywords

Sam Slutsky ,Graig Suvannavejh ,Amylyx Pharmaceuticals Inc ,Rain Therapeutics Inc ,Mizuho Securities ,Brain Therapeutics ,Research Report ,Axsome Therapeutics ,Bioxcel Therapeutics ,Amylyx Pharmaceuticals ,Lifesci Capital ,Therapeutics Inc ,